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without aortic manipulation, was designed. We herein
report our clinical experience.
Material and methods
Description of the AAD. The AAD is a self-expanding
nitinol extraluminal device that consists of a central cylindri-
cal body made of interconnected elliptical arches and 2 sets of
5 pins (0.3 mm thick) radiating from each end (Fig 1). The
stent has an unreleased diameter of about 3.5 mm and a
released diameter of 5.3 mm. The initial version of the device
enables the surgeon to perform the proximal anastomosis only
before the distal one.
With the use of a tubular delivery system, the AAD being
housed in a cartridge at its distal end, an SVG is prepared for
anastomosis by being inserted through the delivery system
and the central part of the AAD, with its proximal 2 to 3 mm
everted over the distal end of the delivery system. The 5 inner
pins of the AAD are then exposed from the cartridge of the
delivery system, a maneuver that makes them protrude and
penetrate the everted segment of the vein (Fig 2). The device
has to be assembled before use. The vein is mounted on the
delivery system before punching, a procedure that takes 4 to 5
minutes.
S ide clamping of the ascending aorta is recognized asa possible cause for the increased incidence of peri-
operative cerebrovascular accidents during myocardial
revascularization.1,2 When cardiopulmonary bypass
(CPB) is used, the proximal anastomosis of the saphe-
nous vein can be performed with a single episode of
crossclamping, avoiding further trauma to the ascend-
ing aorta. However, when the procedure is done without
CPB, aortic side clamping cannot be avoided if a saphe-
nous vein graft (SVG) is used.
A new sutureless aortic anastomotic device (AAD;
Bypass, Ltd, Herzelia, Israel) that allows an anastomo-
sis to be created to the proximal aorta with an SVG,
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A special penetrating and punching device inserted through
a guiding handle creates a 3.2-mm punched out hole in the
unclamped aortic wall (Fig 3). The punching instrument is
then withdrawn from the handle, and backflow from the aorta
is prevented by a sealing ring placed in the handle. Then, the
delivery system loaded with the vein is advanced through the
tubular guiding handle into the lumen of the aorta. Once
inside the lumen, the AAD is fully released from its cartridge
within the delivery system, a maneuver that places the AAD
within the aortic wall, with all pins fully extended (Fig 4).
The inner pins are inside the aorta, partially penetrating the
inner aortic wall (Fig 5), while the outer pins stabilize the
device by anchoring into the aortic adventitia (Fig 6). The
punching and deployment can be performed by one person in
less than 1 minute.
Because the punched out hole has a diameter of 3.2 mm
while the maximal diameter of the self-expanding AAD is
5.3 mm, the central cylindrical component expands, thus
exerting radial pressure on the everted segment of the vein,
pressing it toward the aortic wall, and sealing it circumfer-
entially.
After the release of the AAD, the vein, now filled with
blood, is fully extracted from the delivery system and the
guiding handle and is ready to be anastomosed at its distal
end. In this initial version, the angle that the SVG forms with
the ascending aorta is about 90°.
Clinical experience. Patients were accepted for this oper-
ation according to clinical protocol previously approved by
the ethical committee, and the study was conducted accord-
ing to the European Standard EN 540 “Clinical Investigation
of Medical Devices for Human Subjects” and the Declaration
of Helsinki. Before being involved in the study, patients were
informed of the purpose, rights, duties, strategies, and possi-
ble risks and then confirmed their consent in writing. To be
included in the study, patients had to fulfill all the inclusion
criteria and none of the exclusion criteria.
Fig 1. The AAD.
Fig 2. The distal end of the vein is everted and the inner pins
are allowed to fully penetrate the vein wall. Both the vein and
aorta are from a cadaver.
Fig 3. The punching instrument, inserted in the handle, pen-
etrates the aorta. Both the vein and aorta are from a cadaver.
Fig 4. The AAD inside the aortic lumen (before deployment)
after being inserted through the handle with its covering tube
protruding in the aortic lumen.
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Inclusion criteria 
• Patients have to be scheduled for primary elective iso-
lated coronary artery bypass grafting
• Patients have to agree to attend the follow-up evalua-
tions and sign an informed consent form
Exclusion criteria 
• Emergency operation
• Not a standard isolated coronary bypass operation
• Life expectancy of less than 2 years
• Previous coronary bypass operation
• Participation in another drug or device study
• Severe aortic atherosclerosis in the target anastomotic site
• Some contraindication to use of antiplatelet drugs
• Chronic renal failure
From July 1999 to March 2000, 17 patients who underwent
myocardial revascularization were scheduled to have the
AAD used to perform the proximal anastomosis of the SVG.
Clinical data are shown in Table I. 
Eight patients were operated on with and 9 without CPB.
In all cases the AAD proximal anastomoses were performed
before the institution of CPB and before the distal anasto-
moses were performed. Eleven patients had transcranial
Doppler ultrasonography to detect microemboli during aortic
punching with the AAD. 
Statistical analysis. Results are expressed as mean ± SD
unless otherwise indicated. 
Results
Use of the AAD for proximal anastomosis of the
SVG was attempted in 17 patients and was successful
in 16. In 1 (5.6%) patient the vein was deployed incor-
rectly because the aortic wall was very thick, but the
hole was easily controlled with sutures. Perioperative
use of an epicardial echo probe could be helpful to
check the thickness and the quality of the aortic wall.
Because such a probe is not available in all operating
rooms, we suggested that the manufacturer increase the
length of inner pins by about 1 mm so that the device
can be used safely when the aortic wall is thicker than
normal. In 2 cases, one stitch was necessary because of
minor leakage. Technical details are shown in Tables II
and III. None of the 11 patients in whom transcranial
Fig 5. The AAD after deployment from the delivery system,
as seen from the aortic lumen. The pins allow contact
between the intimas of the vein and of the aorta.
Fig 6. The outer pins stabilize the device by anchoring into
the aortic adventitia.
Table I. Clinical and operative data
Age (y) 62.1 ± 8.8
Female sex 4 (23.5%)
Unstable angina 4 (23.5%)
Ejection fraction 63.2 ± 6.4
Repeat operation 1 (5.8%)
Anastomoses/patient 2.6 ± 0.7
On/off pump 8/9
Table III. SVG distal anastomoses
Total distal anastomoses 18 (2 sequential)
Posterior descending artery 9 (50.1%)
Obtuse marginal 6 (33.3%)
Right coronary artery 2 (11.1%)
Diagonal branch 1 (5.5%)
Table II. Technical details
Device unreleased 1 (5.8%)
Leakage 2 (11.7%)
Perfect device release 14 (82.5%)
Doppler ultrasonography was used had particulate
embolization during aortic punching.
After a mean follow-up period of 4 ± 2 months, no
patient had died or required reoperation for bleeding.
None of the patients had any symptoms of angina dur-
ing the follow-up period. 
Six (35.3%) patients had a follow-up angiogram (48
± 26 days postoperatively). The conduits were all wide-
ly patent (Fig 7).
Discussion
The search for a device that can facilitate vascular
anastomoses is not new. Over the years many authors
have designed and used many techniques, both experi-
mentally and clinically, to bond blood vessels of differ-
ent sizes. Stapling, clipping, coupling, pasting, and
laser welding have been used, with not completely
acceptable results.3 Recently, a one-shot anastomotic
device for end-to-side coronary anastomosis was
designed and commercialized,4,5 but its use is confined
to arteriovenous fistulas for vascular access.
Our approach started from the easiest part of the
problem, with the purpose of designing a stapling
device that allowed an end-to-side anastomosis
between the aorta and an SVG that has a relatively big
internal size. There are several advantages. Aortic
manipulation and, in particular, aortic side clamping4
are considered the main causes of intraoperative cere-
bral embolization during myocardial revascularization
with CPB and are correlated to increased length of stay
and higher incidence of adverse neurologic postopera-
tive outcome.5 In our clinical experience, we found that
the AAD is useful for creating a proximal SVG-aorta
anastomosis, eliminating the need for aortic side
clamping. This can be valuable in myocardial revascu-
larization without CPB because of the risk of particu-
late embolization with side clamping when the SVG is
used. The maneuvers connected with the use of the
device (aortic punching) did not cause microemboliza-
tion from the aorta in any of the patients in whom
emboli were sought. 
The second advantage is the ability to use the aorta as
a blood source in endoscopic surgery, allowing the
saphenous vein to be used as an aorta-coronary graft,
when necessary.
This device is a first-generation AAD. A second gen-
eration will be available shortly, which will address the
two issues that were encountered in the current gener-
ation: immediate leakage encountered in 2 cases and
incorrect deployment in 1 case. We believe that a thick-
er-than-normal aortic wall was responsible for the
incorrect deployment of the AAD. The leakages can be
related to the single size of the delivery system. When
the saphenous vein is small, the system cannot be used,
but it can be used when the saphenous vein is larger
than the AAD. This mismatch between the AAD and
the vein can cause bleeding due to shrinkage of the
vein, a problem that will be solved with the next gen-
eration of the device. A small vein cannot fit the deliv-
ery system; for this reason we encountered no instances
of rupture of the vein due to inadequate size.
Other modifications will be part of the second-gener-
ation AAD:
• The angle between the implanted SVG and the aor-
tic surface is currently about 90°. Although this
works well, the graft needs to be directed in an
acute angle. Currently, it is mandatory to choose
the right location of the proximal anastomosis very
carefully so that the SVG will be oriented as much
as possible toward the target coronary artery. This
is a limitation of the current AAD, especially with
an atheromatous or short aorta.
• The possibility to perform the distal anastomoses
first.
• At least 2 different sizes of AAD to widen SVG
usage, limited now by the width of the vein. At 
present, only one size is available; therefore, a
small-diameter vein (<3 mm) is a contraindication
to use of the device.
• Lengthening of the covering tube of the handle to
allow a thicker aortic wall to be deployed with the
AAD. As mentioned earlier, in the only case in
which the device was unreleased, the aortic wall
was very thick and diseased.
In conclusion, the AAD allows a sutureless SVG
anastomosis. The results presented here show clearly
that the AAD-mediated aorta-SVG anastomosis works
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Fig 7. Postoperative angiogram. The proximal anastomosis is
patent; the vein arises at a 90° angle from the aorta, as indi-
cated by the contrast material in the vein.
Discussion
Dr Robert W. Emery (Minneapolis, Minn). Do you think
this device is going to change the way we approach coronary
surgery? This will change the proximal anastomoses. Are we
going to need to directly visualize the ascending aorta in the
future? 
Dr Calafiore. The manipulation, as seen in the aorta, is one
of the points that must be discussed to simplify myocardial
revascularization, especially in the beating heart. In some
cases the quality of the aorta is poor. In other cases some of
the arterial conduits needed for complete revascularization
are unavailable because of age or comorbidities. The possi-
bility of using the ascending aorta as a blood source for an
SVG without side clamping is appealing. As the AAD is fur-
ther developed, I hope it will be helpful. I do not know
whether it will have a great impact, but in some patients it can
surely be helpful. 
Dr Emery. It seems to me the impact will be quite large. 
Dr Valvanur A. Subramanian (New York, NY). Is this the
same device that Naresh Trehan used in Delhi? One of the
anastomoses fell apart during the middle of the night and the
patient had to be resuscitated. 
Dr Calafiore. I know that Naresh Trehan treated 2 patients.
He does not know the reason for the failure in the 1 patient.
He told me that this device was perfectly reasonable. Our
group worked for a few months and had only 17 patients
because of the limitations of the device and the need to obtain
the consent of the patients. However, we never observed any
complications such as you mentioned. Those devices that we
observed in the operating room remained normal. In Dr
Trehan’s case, I think the AAD may not have been perfect. 
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successfully, and all the clinical outcomes were satisfy-
ing. None of the patients had symptoms of angina, and
those grafts that were reviewed angiographically were
fully patent. A second generation of the AAD will be
available shortly and will address the above-mentioned
improvements. 
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